Applications and continued evolution of glycan imaging mass spectrometry
Mass Spectrometry Reviews · 2023-03 · 42 (2) · 674-705
DOI: 10.1002/mas.21725 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Mass Spectrometry Reviews, online erschienen am 15.08.2021. Verfasst von Colin T McDowell und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, South Carolina, USA. Hauptthemen laut MEDLINE: Polysaccharides. Die Arbeit wurde bisher 77-mal zitiert (Crossref) und nennt 233 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDDK NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Glycosylation is an important posttranslational modifier of proteins and lipid conjugates critical for the stability and function of these macromolecules. Particularly important are N‐linked glycans attached to asparagine residues in proteins. N‐glycans have well‐defined roles in protein folding, cellular trafficking and signal transduction, and alterations to them are implicated in a variety of diseases. However, the non‐template driven biosynthesis of these N‐glycans leads to significant structural diversity, making it challenging to identify the most biologically and clinically relevant species using conventional analyses. Advances in mass spectrometry instrumentation and data acquisition, as well as in enzymatic and chemical sample preparation strategies, have positioned mass spectrometry approaches as powerful analytical tools for the characterization of glycosylation in health and disease. Imaging mass spectrometry expands upon these strategies by capturing the spatial component of a glycan's distribution in‐situ, lending additional insight into the organization and function of these molecules. Herein we review the ongoing evolution of glycan imaging mass spectrometry beginning with widely adopted tissue imaging approaches and expanding to other matrices and sample types with potential research and clinical implications. Adaptations of these techniques, along with their applications to various states of disease, are discussed. Collectively, glycan imaging mass spectrometry analyses broaden our understanding of the biological and clinical relevance of N‐glycosylation to human disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, South Carolina, USA.
Förderung
- NCI NIH HHS
- NIDDK NIH HHS
- NIGMS NIH HHS
- NIA NIH HHS
Zitieren
APA
McDowell, C. T., Lu, X., Mehta, A. S., Angel, P. M., & Drake, R. R. (2023). Applications and continued evolution of glycan imaging mass spectrometry. Mass Spectrometry Reviews, 42(2), 674-705. https://doi.org/10.1002/mas.21725
Vancouver
McDowell CT, Lu X, Mehta AS, Angel PM, Drake RR. Applications and continued evolution of glycan imaging mass spectrometry. Mass Spectrometry Reviews. 2023;42(2):674-705. doi:10.1002/mas.21725
BibTeX
@article{McDowell2023,
author = {McDowell, Colin T and Lu, Xiaowei and Mehta, Anand S and Angel, Peggi M and Drake, Richard R},
title = {Applications and continued evolution of glycan imaging mass spectrometry},
journal = {Mass Spectrometry Reviews},
year = {2023},
volume = {42},
number = {2},
pages = {674--705},
doi = {10.1002/mas.21725}
}
EUVIMED